Your browser doesn't support javascript.
loading
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann, Rebecca; Borden, Brittany A; Danahey, Keith; Nanda, Rita; Polite, Blase N; Stadler, Walter M; Ratain, Mark J; O'Donnell, Peter H.
Afiliación
  • Wellmann R; Pritzker School of Medicine, The University of Chicago, Chicago, Illinois.
  • Borden BA; Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois.
  • Danahey K; Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois.
  • Nanda R; Center for Research Informatics, The University of Chicago, Chicago, Illinois.
  • Polite BN; Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois.
  • Stadler WM; Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Ratain MJ; Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois.
  • O'Donnell PH; Department of Medicine, The University of Chicago, Chicago, Illinois.
Cancer ; 124(14): 3052-3065, 2018 07 15.
Article en En | MEDLINE | ID: mdl-29742281

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacogenética / Biomarcadores de Tumor / Medicina de Precisión / Neoplasias / Antineoplásicos Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacogenética / Biomarcadores de Tumor / Medicina de Precisión / Neoplasias / Antineoplásicos Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article